A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS
Clinical trial NCT04258995 · COMPLETED
Trial details
- NCT number
- NCT04258995
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-11
- Primary completion
- 2020-09-15
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.